ANTARES PHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ewing, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

SEC filing history

Showing 226-250 of 688 matching filings.

Per page
25
Current page
10
8-K File 001-32302

8-K RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Filing date
28 Feb 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Feb 2019
Reporting date
20 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Feb 2019
Reporting date
20 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-47575

SC 13G

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-47575

SC 13G/A filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-47575

SC 13G/A filing

Filing date
04 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K COMPANY PRESENTATION

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Dec 2018
Reporting date
13 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
14 Dec 2018
Reporting date
12 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K ITEM 5.02

Filing date
13 Dec 2018
Reporting date
12 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K

Filing date
15 Nov 2018
Reporting date
15 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K THIRD QUARTER 2018 RESULTS OF OPERATIONS

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Oct 2018
Reporting date
02 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K COMPANY PRESENTATION

Filing date
02 Oct 2018
Reporting date
02 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K INVESTOR PRESENTATION

Filing date
06 Sep 2018
Reporting date
06 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Aug 2018
Reporting date
21 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Aug 2018
Reporting date
13 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Aug 2018
Reporting date
08 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Aug 2018
Reporting date
06 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
07 Aug 2018
Reporting date
06 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K ITEM 2.02 RESULTS OF OPERATION & FINANCIAL CONDITION

Filing date
07 Aug 2018
Reporting date
07 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K

Filing date
14 Jun 2018
Reporting date
08 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .